Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consultant Proposes FDA/Industry Joint Panel In Place Of NDI Guidance

This article was originally published in The Tan Sheet

Executive Summary

FDA should scrap its new dietary ingredient notification guidance in favor of an FDA/industry joint panel that would create safety proposals regarding new ingredients, a consultant says.

You may also be interested in...



People In Brief

ChromaDex shakes up management; Perrigo adds corporate responsibility head; Office of Dietary Supplements adds 2 scientists; Oragenics adds adviser; Kidd joins Doctor's Best; Life Extension promotes Bristol-Myers vet; food safety experts support FDA’s Taylor.

People In Brief

ChromaDex shakes up management; Perrigo adds corporate responsibility head; Office of Dietary Supplements adds 2 scientists; Oragenics adds adviser; Kidd joins Doctor's Best; Life Extension promotes Bristol-Myers vet; food safety experts support FDA’s Taylor.

NDI Guidance Sparks Questions Even From Firms Ready To Comply

FDA’s new dietary ingredient notification draft guidance draws questions even from firms that expect compliance will not require drastic changes in their processes.

Topics

UsernamePublicRestriction

Register

PS105366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel